Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Virginia Borges

Concepts (552)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
133
2024
2101
12.230
 Why?
Pregnancy Complications, Neoplastic
14
2021
50
3.080
 Why?
Postpartum Period
19
2024
328
2.810
 Why?
Receptor, ErbB-2
28
2023
325
2.290
 Why?
Cancer Survivors
17
2024
256
2.250
 Why?
Receptors, Estrogen
19
2021
421
2.010
 Why?
Carcinoma, Ductal, Breast
10
2023
79
1.810
 Why?
Mastectomy
17
2024
132
1.760
 Why?
Antineoplastic Agents, Hormonal
12
2024
155
1.750
 Why?
Antineoplastic Combined Chemotherapy Protocols
18
2023
1559
1.400
 Why?
Lactation
9
2021
175
1.320
 Why?
Carcinoma, Intraductal, Noninfiltrating
7
2023
54
1.180
 Why?
Female
149
2024
68650
1.150
 Why?
Breast
10
2021
140
1.070
 Why?
Antineoplastic Agents
12
2023
2044
1.000
 Why?
Neoplasm Metastasis
10
2020
609
0.980
 Why?
Trastuzumab
13
2023
100
0.960
 Why?
Protein Kinase Inhibitors
6
2021
885
0.930
 Why?
Receptors, Progesterone
6
2021
341
0.900
 Why?
Adult
86
2024
35505
0.900
 Why?
Pregnancy
32
2024
6412
0.890
 Why?
Mammary Glands, Human
7
2020
63
0.880
 Why?
Humans
158
2024
129527
0.850
 Why?
Triple Negative Breast Neoplasms
6
2020
193
0.820
 Why?
Supreme Court Decisions
1
2022
11
0.790
 Why?
Mammary Glands, Animal
9
2021
128
0.740
 Why?
BRCA2 Protein
5
2024
54
0.720
 Why?
Carcinoma
3
2021
213
0.720
 Why?
Brain Neoplasms
9
2023
1149
0.710
 Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2020
34
0.700
 Why?
Drug Resistance, Neoplasm
3
2022
751
0.670
 Why?
Neoadjuvant Therapy
6
2021
378
0.650
 Why?
Maternal Age
1
2020
125
0.650
 Why?
Fertility Preservation
6
2024
39
0.640
 Why?
Estradiol
5
2019
492
0.610
 Why?
Extracellular Vesicles
1
2020
129
0.600
 Why?
Prospective Studies
31
2024
7150
0.590
 Why?
Prognosis
15
2022
3772
0.580
 Why?
Neoplasm Recurrence, Local
13
2023
956
0.580
 Why?
Young Adult
37
2024
12438
0.580
 Why?
Carcinoma in Situ
3
2022
44
0.570
 Why?
Parity
7
2022
120
0.560
 Why?
Lymphatic Metastasis
10
2021
319
0.550
 Why?
Middle Aged
51
2024
31087
0.550
 Why?
Neoplasm Staging
17
2022
1281
0.540
 Why?
Neoplasms, Second Primary
3
2024
106
0.530
 Why?
Quality of Life
11
2024
2694
0.530
 Why?
Cyclooxygenase 2
5
2020
174
0.490
 Why?
Liver Neoplasms
4
2016
635
0.480
 Why?
Semaphorins
3
2020
28
0.470
 Why?
Breast Feeding
5
2024
424
0.470
 Why?
Chemotherapy, Adjuvant
13
2024
376
0.460
 Why?
Antigens, CD
5
2020
485
0.450
 Why?
Aromatase Inhibitors
6
2019
51
0.450
 Why?
Capecitabine
5
2023
45
0.450
 Why?
Carcinoma, Lobular
2
2012
47
0.440
 Why?
Melanoma
4
2018
728
0.440
 Why?
Oxazoles
4
2021
30
0.440
 Why?
Mutation
10
2023
3702
0.440
 Why?
Mastectomy, Segmental
6
2022
86
0.440
 Why?
Skin Neoplasms
4
2013
830
0.430
 Why?
Combined Modality Therapy
10
2023
1201
0.420
 Why?
Puerperal Disorders
2
2014
31
0.420
 Why?
BRCA1 Protein
4
2024
65
0.410
 Why?
Quinazolines
4
2021
241
0.390
 Why?
Stromal Cells
3
2013
106
0.390
 Why?
Biomarkers, Tumor
10
2023
1159
0.380
 Why?
Anxiety
7
2022
976
0.380
 Why?
Tumor Suppressor Protein p53
2
2021
502
0.380
 Why?
Sexual Partners
3
2022
185
0.350
 Why?
Epithelial Cells
6
2018
1061
0.350
 Why?
Nevus, Pigmented
1
2011
32
0.350
 Why?
Disease-Free Survival
7
2023
647
0.340
 Why?
Neoplasm Invasiveness
6
2020
481
0.340
 Why?
Pyridines
4
2021
478
0.340
 Why?
Radiosurgery
3
2021
321
0.340
 Why?
Tamoxifen
7
2021
197
0.330
 Why?
Estrogens
4
2015
346
0.330
 Why?
Cyclophosphamide
5
2020
234
0.320
 Why?
Adjuvants, Immunologic
2
2022
222
0.320
 Why?
Risk Factors
17
2024
9779
0.320
 Why?
Gene Expression Profiling
8
2020
1684
0.310
 Why?
Thrombophilia
1
2009
81
0.310
 Why?
T-Lymphocytes
6
2018
1935
0.300
 Why?
Incidence
7
2024
2643
0.300
 Why?
Neoplasms
6
2022
2450
0.300
 Why?
Doxorubicin
5
2020
328
0.300
 Why?
Gene Expression Regulation, Neoplastic
4
2021
1327
0.290
 Why?
Animals
30
2021
35334
0.280
 Why?
Mice
20
2021
16973
0.280
 Why?
Breast Neoplasms, Male
2
2018
28
0.280
 Why?
Employment
2
2019
167
0.280
 Why?
Kaplan-Meier Estimate
4
2020
850
0.280
 Why?
Fertility
4
2022
155
0.280
 Why?
Cohort Studies
11
2024
5423
0.280
 Why?
Decision Making
4
2022
860
0.280
 Why?
Cell Line, Tumor
9
2020
3181
0.260
 Why?
Myeloid-Derived Suppressor Cells
2
2018
64
0.260
 Why?
Maytansine
2
2018
16
0.260
 Why?
Adaptation, Psychological
2
2022
618
0.260
 Why?
Time Factors
7
2020
6530
0.260
 Why?
Disease Management
3
2021
591
0.250
 Why?
Hematopoietic Stem Cell Transplantation
1
2011
577
0.250
 Why?
CD8-Positive T-Lymphocytes
5
2023
855
0.240
 Why?
GPI-Linked Proteins
3
2020
67
0.240
 Why?
Reproductive History
2
2015
18
0.240
 Why?
Macrophages
4
2018
1486
0.240
 Why?
Class I Phosphatidylinositol 3-Kinases
2
2022
80
0.230
 Why?
Proportional Hazards Models
2
2022
1196
0.230
 Why?
Dimethyl Sulfoxide
1
2005
41
0.230
 Why?
Adolescent
20
2024
20409
0.230
 Why?
Genetic Predisposition to Disease
6
2024
2271
0.230
 Why?
Disease Progression
10
2020
2628
0.220
 Why?
Bupropion
1
2004
40
0.220
 Why?
Spectrometry, Mass, Electrospray Ionization
1
2005
180
0.220
 Why?
Reproductive Techniques, Assisted
1
2024
35
0.220
 Why?
Lymph Nodes
3
2019
471
0.220
 Why?
Premenopause
4
2021
120
0.210
 Why?
Aged
24
2023
22063
0.210
 Why?
Disease Models, Animal
5
2020
4073
0.210
 Why?
Drug Administration Schedule
3
2018
763
0.210
 Why?
Diarrhea
3
2019
180
0.210
 Why?
Estrogen Receptor alpha
2
2021
129
0.210
 Why?
Liver
3
2020
1836
0.210
 Why?
Cell Proliferation
5
2021
2367
0.210
 Why?
Multiple Sclerosis
1
2008
438
0.200
 Why?
Age Factors
9
2021
3150
0.200
 Why?
Hypertension, Pregnancy-Induced
1
2023
67
0.200
 Why?
Pharmaceutical Preparations
1
2005
168
0.200
 Why?
Aurora Kinase A
2
2019
53
0.190
 Why?
Genomic Instability
1
2022
48
0.190
 Why?
Antineoplastic Agents, Immunological
3
2019
181
0.190
 Why?
Chromatography, Liquid
1
2004
424
0.190
 Why?
Proteomics
2
2020
1053
0.190
 Why?
Pilonidal Sinus
1
2001
2
0.190
 Why?
Condylomata Acuminata
1
2001
7
0.190
 Why?
Women's Health
1
2024
364
0.190
 Why?
Hematopoiesis
1
2022
184
0.190
 Why?
Nausea
2
2018
111
0.180
 Why?
Ki-67 Antigen
2
2019
108
0.180
 Why?
Dyspareunia
1
2020
8
0.170
 Why?
Mass Spectrometry
1
2004
717
0.170
 Why?
Cancer Care Facilities
1
2020
32
0.170
 Why?
Body Image
3
2020
84
0.170
 Why?
Tumor Microenvironment
6
2021
627
0.170
 Why?
Mice, Inbred BALB C
6
2019
1248
0.170
 Why?
Carcinoma, Non-Small-Cell Lung
2
2021
1050
0.170
 Why?
Antibodies, Monoclonal, Humanized
6
2021
755
0.170
 Why?
Ibuprofen
2
2018
81
0.170
 Why?
Pregnancy-Associated Plasma Protein-A
1
2020
14
0.170
 Why?
Resistance Training
1
2022
151
0.170
 Why?
Risk
3
2013
857
0.170
 Why?
Neoplasm Grading
5
2021
283
0.170
 Why?
Biopsy
4
2018
1087
0.170
 Why?
Benzodiazepines
1
2021
138
0.160
 Why?
Mice, Inbred NOD
1
2021
587
0.160
 Why?
Bone Neoplasms
2
2016
229
0.160
 Why?
Fatigue
2
2018
319
0.160
 Why?
p21-Activated Kinases
1
2019
15
0.160
 Why?
Sexual Health
1
2020
53
0.160
 Why?
Pyrazoles
3
2018
403
0.160
 Why?
Cell Adhesion
1
2020
454
0.160
 Why?
Social Support
3
2022
586
0.150
 Why?
Receptor, trkB
1
2019
30
0.150
 Why?
Immunohistochemistry
8
2019
1684
0.150
 Why?
Cell Communication
1
2020
298
0.150
 Why?
Sexual Dysfunctions, Psychological
1
2019
34
0.150
 Why?
Carcinoma, Ductal
2
2011
11
0.150
 Why?
Response Evaluation Criteria in Solid Tumors
1
2018
16
0.150
 Why?
Lymphangiogenesis
2
2018
26
0.150
 Why?
Germ Cells
3
2024
60
0.150
 Why?
Nuclear Receptor Subfamily 1, Group F, Member 3
1
2018
12
0.150
 Why?
Ipilimumab
1
2018
31
0.150
 Why?
Tryptophan Oxygenase
1
2018
34
0.150
 Why?
Sexual Dysfunction, Physiological
1
2019
64
0.150
 Why?
Neoplasm Proteins
2
2020
417
0.150
 Why?
Brain-Derived Neurotrophic Factor
1
2019
113
0.150
 Why?
Parenting
1
2022
294
0.150
 Why?
Cisplatin
1
2020
298
0.140
 Why?
Vitamin D
1
2021
379
0.140
 Why?
Area Under Curve
1
2018
306
0.140
 Why?
T-Lymphocytes, Regulatory
2
2018
372
0.140
 Why?
Tretinoin
1
2018
121
0.140
 Why?
Immunity, Mucosal
1
2018
94
0.140
 Why?
Programmed Cell Death 1 Receptor
1
2019
232
0.140
 Why?
Global Health
1
2020
328
0.140
 Why?
Drug Delivery Systems
2
2010
337
0.140
 Why?
Patient Care Management
1
2017
56
0.130
 Why?
Tryptophan
1
2018
177
0.130
 Why?
Socioeconomic Factors
5
2021
1211
0.130
 Why?
Granulocytes
1
2017
77
0.130
 Why?
Case-Control Studies
3
2020
3383
0.130
 Why?
Receptors, Antigen, T-Cell
2
2023
707
0.130
 Why?
Surveys and Questionnaires
8
2024
5429
0.130
 Why?
Carcinoma, Squamous Cell
1
2001
628
0.130
 Why?
United States
7
2024
13865
0.130
 Why?
Neoplasms, Radiation-Induced
1
2016
71
0.130
 Why?
Metaplasia
1
2016
57
0.130
 Why?
Pancreatic Cyst
1
2017
51
0.130
 Why?
Protein-Tyrosine Kinases
1
2019
431
0.130
 Why?
Depression
3
2020
1321
0.130
 Why?
Genetic Testing
2
2016
422
0.130
 Why?
Cell Transformation, Neoplastic
3
2015
318
0.130
 Why?
Radiotherapy, Image-Guided
1
2016
34
0.130
 Why?
Mammography
1
2017
146
0.130
 Why?
Lung Neoplasms
2
2021
2342
0.130
 Why?
Prostatic Neoplasms
2
2021
995
0.130
 Why?
Dyskinesia, Drug-Induced
1
1995
12
0.120
 Why?
Cellular Microenvironment
1
2016
83
0.120
 Why?
Antiparkinson Agents
1
1995
28
0.120
 Why?
Levodopa
1
1995
30
0.120
 Why?
Epithelium
2
2015
311
0.120
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2018
339
0.120
 Why?
Transforming Growth Factor beta3
1
2015
9
0.120
 Why?
Chronic Pain
1
2019
253
0.120
 Why?
Cytophagocytosis
1
2015
8
0.120
 Why?
Prophylactic Surgical Procedures
1
2015
6
0.120
 Why?
Adherens Junctions
1
2015
25
0.120
 Why?
Paracrine Communication
1
2015
59
0.120
 Why?
Rats
6
2021
5470
0.120
 Why?
Phosphoproteins
2
2015
333
0.120
 Why?
Gastrointestinal Microbiome
1
2022
641
0.120
 Why?
Hodgkin Disease
1
2016
133
0.120
 Why?
Risk Reduction Behavior
1
2016
209
0.120
 Why?
Menarche
1
2015
59
0.120
 Why?
Lymphocyte Activation
3
2017
1109
0.120
 Why?
Pyrimidines
1
2018
458
0.120
 Why?
Spleen
1
2017
508
0.120
 Why?
Lymph Node Excision
2
2021
164
0.110
 Why?
Survivors
3
2023
461
0.110
 Why?
Microfilament Proteins
1
2015
127
0.110
 Why?
Survival Analysis
4
2021
1270
0.110
 Why?
Pregnancy Outcome
3
2023
391
0.110
 Why?
Retrospective Studies
9
2021
14532
0.110
 Why?
Extracellular Matrix
2
2016
506
0.110
 Why?
Genes, BRCA2
2
2015
22
0.110
 Why?
Mammary Neoplasms, Animal
1
2014
31
0.110
 Why?
Medication Adherence
1
2019
560
0.110
 Why?
Amenorrhea
1
2014
27
0.110
 Why?
Odds Ratio
4
2020
1018
0.110
 Why?
Genes, BRCA1
2
2015
30
0.110
 Why?
Calcium-Binding Proteins
1
2015
212
0.110
 Why?
Brain Edema
1
2014
61
0.110
 Why?
Multivariate Analysis
2
2019
1491
0.110
 Why?
Collagen
2
2021
436
0.110
 Why?
Monocytes
1
2017
554
0.110
 Why?
Spouses
1
2015
103
0.110
 Why?
Male
19
2022
63586
0.110
 Why?
Tremor
1
1994
60
0.110
 Why?
Astrocytes
1
2015
197
0.110
 Why?
Signal Transduction
4
2020
4916
0.110
 Why?
Neoplastic Cells, Circulating
2
2016
70
0.110
 Why?
Cross-Sectional Studies
5
2022
5078
0.110
 Why?
Nitriles
1
2014
169
0.100
 Why?
Antigens, Differentiation, Myelomonocytic
3
2019
59
0.100
 Why?
Infertility, Female
1
2014
102
0.100
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2012
952
0.100
 Why?
Analgesics, Opioid
1
2021
919
0.100
 Why?
Trans-Activators
1
2015
392
0.100
 Why?
Triazoles
1
2014
148
0.100
 Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2012
25
0.100
 Why?
Lymphatic Vessels
3
2019
61
0.100
 Why?
Genome-Wide Association Study
1
2019
1326
0.100
 Why?
Myeloid Cells
1
2013
141
0.100
 Why?
Drug Design
1
2013
157
0.100
 Why?
Mice, Inbred C57BL
6
2019
5468
0.100
 Why?
Live Birth
2
2023
57
0.100
 Why?
Logistic Models
5
2016
1983
0.100
 Why?
Genes, Bacterial
1
2012
159
0.090
 Why?
Apoptosis
3
2019
2488
0.090
 Why?
Wound Healing
1
2014
308
0.090
 Why?
Transcriptome
2
2021
875
0.090
 Why?
Double-Blind Method
3
2021
1873
0.090
 Why?
Fibrillar Collagens
1
2011
14
0.090
 Why?
Interpersonal Relations
1
2015
394
0.090
 Why?
Treatment Outcome
7
2021
10232
0.090
 Why?
Progesterone
1
2013
244
0.090
 Why?
Patient Participation
1
2015
412
0.090
 Why?
Real-Time Polymerase Chain Reaction
1
2012
328
0.090
 Why?
Membrane Proteins
2
2015
1118
0.090
 Why?
Antigen Presentation
2
2018
207
0.090
 Why?
Streptococcus agalactiae
1
2012
93
0.090
 Why?
Xenograft Model Antitumor Assays
3
2020
804
0.090
 Why?
Biopsy, Needle
1
2011
187
0.090
 Why?
Adenocarcinoma
2
2015
889
0.080
 Why?
Estrogen Antagonists
1
2010
45
0.080
 Why?
Parkinson Disease
1
1995
462
0.080
 Why?
Sexual Behavior
1
2014
481
0.080
 Why?
Clinical Trials as Topic
3
2017
1001
0.080
 Why?
Cell Fusion
2
2006
51
0.080
 Why?
Pregnancy Trimester, Second
1
2009
77
0.080
 Why?
Radiotherapy, Adjuvant
2
2021
208
0.080
 Why?
Sentinel Lymph Node Biopsy
3
2021
108
0.080
 Why?
Mucin-1
1
2009
19
0.080
 Why?
Cell Movement
3
2019
942
0.080
 Why?
Reference Standards
2
2012
176
0.080
 Why?
Drug Monitoring
1
2010
214
0.080
 Why?
Interferon beta-1a
1
2008
12
0.080
 Why?
In Situ Hybridization, Fluorescence
3
2019
305
0.080
 Why?
Glatiramer Acetate
1
2008
18
0.080
 Why?
Pregnancy Trimester, First
1
2009
137
0.080
 Why?
Macrophage Activation
1
2010
189
0.080
 Why?
Apoptosis Regulatory Proteins
1
2009
182
0.070
 Why?
Rats, Sprague-Dawley
4
2016
2393
0.070
 Why?
Clinical Trials, Phase I as Topic
2
2020
51
0.070
 Why?
Quinolines
2
2021
156
0.070
 Why?
Dose-Response Relationship, Drug
3
2018
2013
0.070
 Why?
Interferon-beta
1
2008
89
0.070
 Why?
Metalloproteases
1
2008
43
0.070
 Why?
Sensitivity and Specificity
3
2013
1842
0.070
 Why?
Aged, 80 and over
5
2020
7052
0.070
 Why?
Extracellular Matrix Proteins
1
2009
144
0.070
 Why?
Gonadal Steroid Hormones
1
2009
131
0.070
 Why?
Age of Onset
2
2021
495
0.070
 Why?
Genomics
2
2023
715
0.070
 Why?
Cell Cycle
2
2021
583
0.070
 Why?
Intercellular Signaling Peptides and Proteins
1
2009
373
0.070
 Why?
Follow-Up Studies
3
2024
4891
0.070
 Why?
Maximum Tolerated Dose
2
2018
193
0.070
 Why?
Disease Susceptibility
1
2009
333
0.070
 Why?
HIV Infections
1
2001
2729
0.070
 Why?
Antibodies, Monoclonal
3
2009
1366
0.070
 Why?
ErbB Receptors
3
2017
605
0.070
 Why?
Gene Knockdown Techniques
2
2020
315
0.070
 Why?
Sternum
1
2006
25
0.060
 Why?
Mice, Nude
3
2015
677
0.060
 Why?
Membrane Glycoproteins
2
2019
477
0.060
 Why?
Cell Survival
2
2020
1084
0.060
 Why?
Polymerase Chain Reaction
2
2016
1031
0.060
 Why?
Postmenopause
2
2005
349
0.060
 Why?
Ovariectomy
2
2019
137
0.060
 Why?
Cells, Cultured
3
2019
4087
0.060
 Why?
Mammaplasty
2
2021
101
0.060
 Why?
Administration, Oral
2
2018
783
0.060
 Why?
Child
6
2022
20932
0.060
 Why?
Axilla
2
2021
46
0.060
 Why?
Models, Biological
2
2012
1717
0.060
 Why?
Forkhead Transcription Factors
2
2018
184
0.060
 Why?
Infant, Newborn
2
2023
5769
0.060
 Why?
Fear
2
2021
333
0.060
 Why?
Dendritic Cells
2
2005
481
0.060
 Why?
Enzyme Inhibitors
1
2008
825
0.060
 Why?
Solubility
1
2005
232
0.060
 Why?
Analysis of Variance
3
2014
1286
0.060
 Why?
Ovulation Induction
1
2024
52
0.060
 Why?
Neoplastic Processes
1
2023
4
0.050
 Why?
Cancer Vaccines
1
2005
164
0.050
 Why?
Weaning
2
2016
48
0.050
 Why?
Multiple Myeloma
1
2005
125
0.050
 Why?
North America
1
2024
294
0.050
 Why?
Cryopreservation
1
2024
94
0.050
 Why?
Celecoxib
2
2014
39
0.050
 Why?
Peptide YY
1
2022
13
0.050
 Why?
Peptides
1
2008
925
0.050
 Why?
Ghrelin
1
2022
32
0.050
 Why?
Withholding Treatment
1
2023
71
0.050
 Why?
DNA End-Joining Repair
1
2022
18
0.050
 Why?
Sensation
1
2022
51
0.050
 Why?
Cost of Illness
1
2024
276
0.050
 Why?
Appetite
1
2022
61
0.050
 Why?
Mucins
1
2022
70
0.050
 Why?
Colorado
3
2020
4403
0.050
 Why?
Chromosome Aberrations
1
2022
140
0.050
 Why?
Referral and Consultation
1
2007
732
0.050
 Why?
Heterozygote
1
2022
270
0.050
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2023
336
0.050
 Why?
Chemoradiotherapy, Adjuvant
1
2021
41
0.050
 Why?
Psychiatric Status Rating Scales
2
2015
533
0.050
 Why?
Reproducibility of Results
2
2012
3081
0.050
 Why?
Genes, p53
1
2021
70
0.050
 Why?
Clinical Trials, Phase III as Topic
1
2021
94
0.050
 Why?
Hypertrophy
1
2021
124
0.050
 Why?
In Situ Hybridization
1
2001
296
0.050
 Why?
Placebos
1
2021
200
0.040
 Why?
Protective Agents
1
2021
39
0.040
 Why?
DNA Repair
1
2022
210
0.040
 Why?
DNA Replication
1
2022
225
0.040
 Why?
Neoplasm, Residual
1
2021
121
0.040
 Why?
Immunity
1
2021
138
0.040
 Why?
CD4-Positive T-Lymphocytes
2
2019
1058
0.040
 Why?
Hormones
1
2021
140
0.040
 Why?
Patient Reported Outcome Measures
1
2024
374
0.040
 Why?
Pregnancy Rate
1
2020
59
0.040
 Why?
Hospitals, University
1
2021
179
0.040
 Why?
Cross-Over Studies
1
2022
522
0.040
 Why?
Multicenter Studies as Topic
1
2021
287
0.040
 Why?
Arm
1
2021
106
0.040
 Why?
Flow Cytometry
3
2013
1158
0.040
 Why?
Morbidity
1
2021
300
0.040
 Why?
Kidney Neoplasms
1
2004
346
0.040
 Why?
Consolidation Chemotherapy
1
2019
9
0.040
 Why?
Confidence Intervals
1
2020
316
0.040
 Why?
SEER Program
1
2021
202
0.040
 Why?
Age Distribution
1
2020
371
0.040
 Why?
Energy Intake
1
2022
462
0.040
 Why?
Terminology as Topic
1
2021
203
0.040
 Why?
DNA, Viral
1
2001
347
0.040
 Why?
Fibronectins
1
2020
126
0.040
 Why?
Unemployment
1
2019
43
0.040
 Why?
Base Sequence
2
2016
2138
0.040
 Why?
Vaginal Diseases
1
2019
21
0.040
 Why?
Sulfonamides
2
2014
497
0.040
 Why?
Immunotherapy
2
2014
596
0.040
 Why?
Leuprolide
1
2019
19
0.040
 Why?
Mammary Neoplasms, Experimental
1
2019
65
0.040
 Why?
Weight Gain
1
2022
510
0.040
 Why?
Interleukin-10
2
2014
298
0.040
 Why?
Crosses, Genetic
1
2018
134
0.040
 Why?
Hot Flashes
1
2019
82
0.040
 Why?
Maintenance Chemotherapy
1
2018
22
0.040
 Why?
Factor Analysis, Statistical
1
2019
282
0.040
 Why?
Proto-Oncogene Proteins c-myc
1
2019
128
0.040
 Why?
Integrins
1
2018
93
0.040
 Why?
Body Weight
1
2022
941
0.040
 Why?
Antimetabolites, Antineoplastic
1
2018
91
0.040
 Why?
Phenotype
2
2020
3058
0.040
 Why?
Kynurenine
1
2018
113
0.030
 Why?
RNA, Small Interfering
1
2020
590
0.030
 Why?
Contraceptives, Oral
1
2017
38
0.030
 Why?
Behavior
1
2018
92
0.030
 Why?
Patient Satisfaction
1
2021
636
0.030
 Why?
B7-H1 Antigen
1
2019
198
0.030
 Why?
Dietary Supplements
1
2021
532
0.030
 Why?
Weight Loss
1
2022
738
0.030
 Why?
Educational Status
1
2019
469
0.030
 Why?
Tumor Escape
1
2017
39
0.030
 Why?
Lymphocytes, Tumor-Infiltrating
1
2018
204
0.030
 Why?
National Cancer Institute (U.S.)
1
2016
43
0.030
 Why?
Stress Disorders, Post-Traumatic
1
2024
812
0.030
 Why?
Risk Assessment
2
2020
3255
0.030
 Why?
Emulsions
1
2016
51
0.030
 Why?
Drug Therapy, Combination
1
2019
1037
0.030
 Why?
Alleles
1
2019
843
0.030
 Why?
Cell Count
1
2017
318
0.030
 Why?
Population Surveillance
1
2019
440
0.030
 Why?
Immune Tolerance
1
2018
356
0.030
 Why?
Radiotherapy Dosage
1
2016
251
0.030
 Why?
Randomized Controlled Trials as Topic
1
2021
1368
0.030
 Why?
Immunophenotyping
1
2017
310
0.030
 Why?
Radiotherapy Planning, Computer-Assisted
1
2016
124
0.030
 Why?
Body Mass Index
2
2015
2269
0.030
 Why?
Antigens, Differentiation
1
2015
82
0.030
 Why?
Medicare
1
2021
716
0.030
 Why?
Molecular Targeted Therapy
1
2018
391
0.030
 Why?
Biomarkers
2
2021
3968
0.030
 Why?
Hybrid Cells
2
2005
48
0.030
 Why?
Directive Counseling
1
2015
47
0.030
 Why?
Cognition
1
2022
1125
0.030
 Why?
Reproduction
1
2016
198
0.030
 Why?
Amyloid Precursor Protein Secretases
1
2015
78
0.030
 Why?
Terminal Care
1
2018
215
0.030
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2017
244
0.030
 Why?
Clinical Decision-Making
1
2017
304
0.030
 Why?
Genotype
1
2019
1827
0.030
 Why?
Tumor Burden
1
2015
287
0.030
 Why?
Leukocyte Common Antigens
1
2014
82
0.030
 Why?
Child, Preschool
2
2021
10499
0.030
 Why?
Dinoprostone
1
2014
187
0.030
 Why?
STAT5 Transcription Factor
1
2013
48
0.030
 Why?
Blood Cell Count
1
2013
52
0.030
 Why?
Dermoscopy
1
2013
10
0.030
 Why?
Wnt Signaling Pathway
1
2015
169
0.030
 Why?
Massachusetts
1
2014
158
0.030
 Why?
Necrosis
1
2014
234
0.030
 Why?
Immunoblotting
1
2014
303
0.030
 Why?
beta Catenin
1
2015
224
0.030
 Why?
Opioid-Related Disorders
1
2021
484
0.030
 Why?
Oncogenes
1
2013
110
0.030
 Why?
Endothelial Cells
1
2018
739
0.030
 Why?
Family Health
1
1994
198
0.030
 Why?
Lipopolysaccharide Receptors
1
2013
85
0.030
 Why?
Karyotyping
1
2012
99
0.030
 Why?
Immune System
1
2014
174
0.020
 Why?
Gonadotropin-Releasing Hormone
1
2014
203
0.020
 Why?
Adiposity
1
2017
504
0.020
 Why?
Observer Variation
1
2013
314
0.020
 Why?
Menopause
1
2015
297
0.020
 Why?
Comorbidity
1
2017
1548
0.020
 Why?
Carcinogenesis
1
2013
211
0.020
 Why?
Cell Division
1
2013
787
0.020
 Why?
Recurrence
1
2015
1011
0.020
 Why?
Calibration
1
2012
140
0.020
 Why?
Tomography, X-Ray Computed
2
2015
2503
0.020
 Why?
Mice, Knockout
1
2018
2887
0.020
 Why?
Polymorphism, Single Nucleotide
1
2019
2062
0.020
 Why?
Palliative Care
1
2018
704
0.020
 Why?
Interferon-gamma
2
2005
773
0.020
 Why?
RNA, Bacterial
1
2012
181
0.020
 Why?
Severity of Illness Index
1
2019
2734
0.020
 Why?
Cell Differentiation
1
2018
1895
0.020
 Why?
Genome, Human
1
2013
393
0.020
 Why?
Self Report
1
2015
800
0.020
 Why?
Photochemotherapy
1
2010
32
0.020
 Why?
Cell Line
1
2016
2774
0.020
 Why?
Mice, SCID
1
2011
350
0.020
 Why?
Feasibility Studies
1
2014
869
0.020
 Why?
Universities
1
2013
406
0.020
 Why?
Gene Expression Regulation, Bacterial
1
2012
324
0.020
 Why?
Survival Rate
1
2014
1870
0.020
 Why?
Microscopy, Confocal
1
2010
318
0.020
 Why?
Hypertension
1
2018
1235
0.020
 Why?
Matrix Metalloproteinases
1
2010
91
0.020
 Why?
Keratin-19
1
2009
3
0.020
 Why?
Immunomagnetic Separation
1
2009
3
0.020
 Why?
Physician-Patient Relations
1
2014
539
0.020
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2009
20
0.020
 Why?
Dose-Response Relationship, Immunologic
1
2009
82
0.020
 Why?
Diagnosis, Differential
1
2013
1422
0.020
 Why?
Vinblastine
1
2009
69
0.020
 Why?
Blotting, Western
1
2011
1199
0.020
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2009
90
0.020
 Why?
Flavonoids
1
2009
76
0.020
 Why?
Species Specificity
1
2010
568
0.020
 Why?
ADAM12 Protein
1
2008
4
0.020
 Why?
Perilipin-1
1
2008
17
0.020
 Why?
Estrogen Receptor Modulators
1
2008
17
0.020
 Why?
Sex Factors
1
1994
1966
0.020
 Why?
S100 Proteins
1
2008
35
0.020
 Why?
ADAM Proteins
1
2008
59
0.020
 Why?
Perimenopause
1
2008
60
0.020
 Why?
Prevalence
1
2014
2561
0.020
 Why?
DNA Primers
1
2009
507
0.020
 Why?
Radiotherapy
1
2008
185
0.020
 Why?
Androstadienes
1
2008
106
0.020
 Why?
Matrix Metalloproteinase 9
1
2008
123
0.020
 Why?
Piperidines
1
2009
200
0.020
 Why?
Gene Expression
1
2012
1461
0.020
 Why?
Chi-Square Distribution
1
2008
515
0.020
 Why?
Precancerous Conditions
1
2008
160
0.020
 Why?
Cluster Analysis
1
2008
483
0.020
 Why?
Protein Structure, Tertiary
1
2009
842
0.020
 Why?
Pleural Effusion
1
2006
51
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2008
754
0.020
 Why?
Lymphocyte Culture Test, Mixed
1
2005
50
0.020
 Why?
Cytotoxicity Tests, Immunologic
1
2005
41
0.020
 Why?
Receptors, CCR7
1
2005
28
0.020
 Why?
Receptors, Chemokine
1
2005
45
0.010
 Why?
Antigens, CD34
1
2005
88
0.010
 Why?
Positron-Emission Tomography
1
2006
282
0.010
 Why?
Interleukin-12
1
2005
118
0.010
 Why?
Hemocyanins
1
2004
62
0.010
 Why?
Stress, Psychological
1
2012
1067
0.010
 Why?
Patient Care Planning
1
2005
146
0.010
 Why?
Carrier Proteins
1
2008
740
0.010
 Why?
Coculture Techniques
1
2004
224
0.010
 Why?
Cell Nucleus
1
2006
589
0.010
 Why?
Cell Separation
1
2004
315
0.010
 Why?
Tumor Cells, Cultured
1
2004
931
0.010
 Why?
Brain
1
2014
2675
0.010
 Why?
Paclitaxel
1
2003
217
0.010
 Why?
Pilot Projects
1
2003
1594
0.010
 Why?
Vaccination
1
2004
1348
0.010
 Why?
Borges's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (552) concept(s)
_
Co-Authors Expand Description
See all (70) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)